GlycoMimetics GLYC 深 滬
等待開盤 08-13 09:30:00 美东时间
0.157
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.157
- 總市值 1013.15万
- 52周最高 63.00
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 14.06
- 委 比 0.00%
- 總股本 6453.21万
- 歷史最高 2605.00
- 量 比 0
- 振 幅 0.00%
- 歷史最低 14.06
- 每 手 1
- 風險率 1.18%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Geron taps Harout Semerjian as CEO
Geron (NASDAQ:GERN) has appointed Harout Semerjian as president and chief executive officer and a member of the board of directors, effective August 7,2025. Semerjian will succeed Dawn Carter Bir, who...
08-06 20:40
Crescent Biopharma Completes Merger with GlycoMimetics
GlycoMimetics ( ($GLYC) ) has provided an announcement. On June 16, 2025, Cresc...
06-19 05:49
Why Beyond Air Shares Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket
Shares of Beyond Air, Inc. (NASDAQ:XAIR) fell sharply in today's pre-market tra...
06-18 18:14
What Does the Market Think About GlycoMimetics?
GlycoMimetics's (NYSE:GLYC) short percent of float has fallen 8.14% since its l...
06-07 01:00
GlycoMimetics shares are trading higher after the company approved the proposed merger with Crescent Biopharma and announced a 1-for-100 reverse stick split.
GlycoMimetics shares are trading higher after the company approved the proposed...
06-06 04:04
GlycoMimetics Announces Merger Amidst Uncertainties
GlycoMimetics ( ($GLYC) ) has provided an announcement. GlycoMimetics has annou...
05-30 20:58
GlycoMimetics Merger-Bound Crescent Appoints Joshua Brumm As CEO
Crescent also appointed Jonathan McNeill, president and chief operating officer; Ellie Im, M.D., chief medical officer; Rick Scalzo, MBA, chief financial officer; and Amy Reilly, chief communications officer.
04-03 19:34
Cantor Fitzgerald Initiates Coverage On GlycoMimetics with Overweight Rating
Cantor Fitzgerald analyst Eric Schmidt initiates coverage on GlycoMimetics (NASDAQ:GLYC) with a Overweight rating.
03-21 22:12
GlycoMimetics Faces Leadership Changes Amid Board Resignations
The latest update is out from GlycoMimetics ( ($GLYC) ). On February 19, 2025, ...
02-26 06:29
Crescent Biopharma Strengthens Leadership Team with Appointment of Three Key Executives
New appointees reinforce the Company's momentum in building a leading oncology therapeutics company Lead asset CR-001, a tetravalent PD-1 x VEGF bispecific antibody, on track for IND filing ...
02-25 05:30
